Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Eli Lilly has not said why it is seeing this shortage The shortage will only affect vials of insulin, not the pens, which doctors hope will help alleviate some of the panic people may be experiencing.
After years of preparation, Eli Lilly is on the brink of launching ... The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device ...
An Eli Lilly official said decades of insulin research and manufacturing ... A Novo Nordisk official said the company makes ...
80% of people with diabetes live in low- and middle-income countries, where access to insulin pens is extremely limited due primarily to high prices Eli Lilly, Novo Nordisk, and Sanofi control and ...
In a press release, drug giant Eli Lilly announced ... diabetes drug insulin. "It’s old school, but I have patients with type 1 and 2 diabetes who prefer vial and syringe to pen devices ...
An Eli Lilly official said decades of insulin research ... more than a dozen insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our work for people ...